Zdrowie i gospodarka · 13/02/2015
FDA Clears SUBUTEX Sublingual Tablets for Continued Sale
The FDA has determined that SUBUTEX Sublingual Tablets, containing 2mg and 8mg of buprenorphine hydrochloride, were not withdrawn from sale due to safety or effectiveness concerns, allowing the tablets to remain on the market.